Study on chemotherapy resistance in high-grade ovarian cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study is for people with a specific type of ovarian cancer (high-grade serous) who have not yet had surgery. It looks at how the cancer may resist standard chemotherapy and aims to find ways to overcome that resistance.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 25 years old or older.
- You have been diagnosed with high-grade serous ovarian cancer.
- You have not had surgery for your ovarian cancer yet.
- Tumor tissue from your primary or metastatic cancer is available for testing.
- You do not have other serious medical conditions or another type of cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized cancer therapy designed just for you and your tumor. It is for people with newly diagnosed advanced ovarian cancer who can wait a short time before starting treatment and plan to have surgery after 2 cycles of chemotherapy.
This trial uses artificial intelligence to guide personalized treatment for people with a specific type of ovarian cancer (high-grade serous carcinoma). It aims to improve outcomes by analyzing your tumor tissue and medical history.
This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.
This study is looking at how ovarian cancer affects the mesentery (the tissue that holds your intestines in place) in women with advanced ovarian cancer. It helps doctors understand the disease better and may lead to improved treatments.
This study looks at a protein called RPL8 in a specific type of ovarian cancer called high-grade serous ovarian carcinoma. It may help researchers understand the disease better and find new ways to treat it.
This trial uses a special imaging technique to study high-grade serous ovarian cancer. It aims to better understand the tumor to improve treatment. If you have advanced ovarian cancer and are scheduled for surgery, you may be eligible.
Hear when a new High-grade Serous Ovarian Carcinoma (HGSOC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.